Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-11-17
2009-12-15
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S443000, C604S020000
Reexamination Certificate
active
07632859
ABSTRACT:
By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corneum which was higher than the one previously obtained with conventional passive diffusion systems.
REFERENCES:
patent: 4801586 (1989-01-01), Minaskanian et al.
patent: 4808414 (1989-02-01), Peck et al.
patent: 4847253 (1989-07-01), Buonamici et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 4917896 (1990-04-01), Peck et al.
patent: 4973468 (1990-11-01), Chiang et al.
patent: 4996226 (1991-02-01), Horn
patent: 5034386 (1991-07-01), Peck et al.
patent: 5043441 (1991-08-01), Peck et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5071645 (1991-12-01), Johnson et al.
patent: 5071875 (1991-12-01), Horn et al.
patent: 5073544 (1991-12-01), Peck et al.
patent: 5091186 (1992-02-01), Miranda et al.
patent: 5108991 (1992-04-01), Rajadhyaksha
patent: 5118845 (1992-06-01), Peck et al.
patent: 5124157 (1992-06-01), Colley et al.
patent: 5142044 (1992-08-01), Minaskanian et al.
patent: 5147916 (1992-09-01), Sweet
patent: 5151446 (1992-09-01), Horn et al.
patent: 5204339 (1993-04-01), Minaskanian et al.
patent: 5225198 (1993-07-01), Sharma et al.
patent: 5234690 (1993-08-01), Chiang et al.
patent: 5234945 (1993-08-01), Belluzzi
patent: 5246997 (1993-09-01), Sweet
patent: 5252334 (1993-10-01), Chiang et al.
patent: 5252335 (1993-10-01), Chiang
patent: 5271940 (1993-12-01), Cleary et al.
patent: 5273755 (1993-12-01), Venkatraman et al.
patent: 5273756 (1993-12-01), Fallon et al.
patent: 5273757 (1993-12-01), Jaeger et al.
patent: 5308625 (1994-05-01), Wong et al.
patent: 5382596 (1995-01-01), Sleevi et al.
patent: 5393529 (1995-02-01), Hoffmann et al.
patent: 5456745 (1995-10-01), Roreger et al.
patent: 5472946 (1995-12-01), Peck et al.
patent: 5519034 (1996-05-01), Kozlik et al.
patent: 5532278 (1996-07-01), Aberg et al.
patent: 5554381 (1996-09-01), Roos et al.
patent: 5601839 (1997-02-01), Quan et al.
patent: 5670164 (1997-09-01), Meconi et al.
patent: 5670501 (1997-09-01), Peck et al.
patent: 5677346 (1997-10-01), Aberg et al.
patent: 5688524 (1997-11-01), Hsu et al.
patent: 5733571 (1998-03-01), Sackler
patent: 5771890 (1998-06-01), Tamada
patent: 5807570 (1998-09-01), Chen et al.
patent: 5834010 (1998-11-01), Quan et al.
patent: 5840336 (1998-11-01), Hsu et al.
patent: 5876746 (1999-03-01), Jona et al.
patent: 5879701 (1999-03-01), Aduett et al.
patent: 5891461 (1999-04-01), Jona et al.
patent: 5902603 (1999-05-01), Chen et al.
patent: 5906830 (1999-05-01), Farinas et al.
patent: 5962013 (1999-10-01), Wong et al.
patent: 5980932 (1999-11-01), Chiang et al.
patent: 5981524 (1999-11-01), Peck et al.
patent: 6010716 (2000-01-01), Saunal et al.
patent: 6024974 (2000-02-01), Li
patent: 6024976 (2000-02-01), Miranda et al.
patent: 6057371 (2000-05-01), Glennon
patent: 6063398 (2000-05-01), Gueret
patent: 6086905 (2000-07-01), Peck et al.
patent: 6218421 (2001-04-01), King
patent: 6221627 (2001-04-01), Sathe et al.
patent: 6242572 (2001-06-01), Tsui et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 6300365 (2001-10-01), Holman
patent: 6316022 (2001-11-01), Mantelle et al.
patent: 6344342 (2002-02-01), Tsui et al.
patent: 6393318 (2002-05-01), Conn et al.
patent: 6398562 (2002-06-01), Butler et al.
patent: 6416503 (2002-07-01), Suzuki et al.
patent: 6465004 (2002-10-01), Rossi-Montero et al.
patent: 6514530 (2003-02-01), Skluzacek et al.
patent: 6620429 (2003-09-01), Müller
patent: 6685959 (2004-02-01), Moreau et al.
patent: 6687522 (2004-02-01), Tamada
patent: 6699498 (2004-03-01), Müller
patent: 6884434 (2005-04-01), Muller et al.
patent: 6899894 (2005-05-01), Klein et al.
patent: 7038085 (2006-05-01), Rariy et al.
patent: 2001/0053777 (2001-12-01), Brecht
patent: 2002/0010201 (2002-01-01), Brecht
patent: 2002/0110585 (2002-08-01), Godbey et al.
patent: 2003/0027793 (2003-02-01), Lauterback et al.
patent: 2003/0166709 (2003-09-01), Rimpler et al.
patent: 2004/0057985 (2004-03-01), Bracht
patent: 2004/0081683 (2004-04-01), Schact et al.
patent: 2004/0110673 (2004-06-01), Steinkasserer et al.
patent: 2004/0137045 (2004-07-01), Breitenbach et al.
patent: 2004/0142904 (2004-07-01), Rariy et al.
patent: 2005/0032873 (2005-02-01), Hatzenbuhler et al.
patent: 2005/0033065 (2005-02-01), Mueller et al.
patent: 2005/0079206 (2005-04-01), Schacht et al.
patent: 2005/0107397 (2005-05-01), Galambos et al.
patent: 2005/0136101 (2005-06-01), Berthold
patent: 2005/0175678 (2005-08-01), Breitenbach
patent: 2005/0175680 (2005-08-01), Morgan et al.
patent: 2005/0182090 (2005-08-01), Mierau et al.
patent: 2005/0197385 (2005-09-01), Scheller et al.
patent: 2006/0222691 (2006-10-01), Cantor et al.
patent: 746856 (1999-10-01), None
patent: 2532804 (2005-02-01), None
patent: 2532859 (2005-02-01), None
patent: 2547820 (2005-06-01), None
patent: 2546797 (2005-07-01), None
patent: 2568850 (2006-02-01), None
patent: 4325855 (1995-02-01), None
patent: WO 93/07842 (1993-04-01), None
patent: WO93/14727 (1993-08-01), None
patent: WO93/16073 (1993-08-01), None
patent: WO 94/04109 (1994-03-01), None
patent: WO 94/07468 (1994-04-01), None
patent: WO94/21244 (1994-09-01), None
patent: WO94/26703 (1994-11-01), None
patent: WO 95/00122 (1995-01-01), None
patent: WO 95/01767 (1995-01-01), None
patent: WO 95/05137 (1995-02-01), None
patent: WO 95/05138 (1995-02-01), None
patent: WO96/00110 (1996-01-01), None
patent: WO 96/22083 (1996-07-01), None
patent: WO 96/22084 (1996-07-01), None
patent: WO 96/40087 (1996-12-01), None
patent: WO 97/09971 (1997-03-01), None
patent: WO 97/29735 (1997-08-01), None
patent: WO 99/49852 (1999-10-01), None
patent: WO 02/15903 (2002-02-01), None
patent: WO2005/063236 (2005-07-01), None
patent: WO2006/050976 (2006-03-01), None
Panchagnula et al. Transdermal iontophoresis revisted. Curr Op Chem Biol., 2000, 4:468-473.
Van der Geest, Ronald, et al., “Iontophoretic Delivery of Apomorphine: In Vitro Optimization and Validation”. Pharm. Res., vol. 14, 1797-1802, 1997.
Li, G., et al., “Optimization of Transdermal Iontophoretic Delivery of Apomorphine for the Treatment of Parkinson's Disease In Vitro”. Proceed. Int'l Symp. Control. Rel. Bioact. Mater., vol. 27, No. 7435, 2000.
Luzardo-Alverez, Asteria, et al., “Iontophoretic Delivery of Ropinirole Hydrochloride: Effect of Current Density and Vehicle Formulation”. Pharm. Res., vol. 18, No. 12, pp. 1714-1720, Dec. 2001.
den Daas, Isaak, et al., “Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning model”. Naunyn-Schmiedeberg's Arch. Pharmacol., vol. 342, pp. 655-659, 1990.
Danhof, M., et al., “An integrated pharmacokinetic-pharmacodynamic approach to optimization ofR-apomorphine delivery in Parkinson's disease”. Advanced Drug Delivery Reviews, vol. 33, pp. 253-263, 1998.
Li, G., et al., “Iontophoretic Delivery of Apomorphine In Vitro: Physicochemic Considerations”. Pharm. Res., vol. 18, No. 11, pp. 1509-1513, Nov. 2001.
Van der Geest, R., et al., “Validation and testing of a new iontophoretic continuous flow through transport cell”. Journal of Controlled Release, vol. 51, pp. 85-91, 1998.
Blindauer (2003) Arch. Neurol. 60(12): 1721-1728.
Hsu et al. (1992) Cygnus Therapeutic Systems Project Report N-0923, 2-19.
Levien et al. (2005) Advances in Pharmacy 3(1): 62-92.
Löschmann et al. (1989) Eur. J. Pharmacol. 166: 373-380.
Pfister (1988) Drug and Cosmetic Ind. (Oct.): 44-52.
Pfister (1989) Pharm. Tech. (Mar.): 126-138.
Pfister and Hsieh (1990) Pharm. Tech. (Sep.): 132-140.
Pfister and Hsieh (1990) Pharm. Tech. (Oct.): 54-60.
Pfister et al. (1991) Chemistry in Britain (Jan.): 43-46.
Pfister et al. (1992) Pharm. Tech. (Jan.): 42-58 and 83.
Roy et al. (1996) J. Pharn. Science 85(5): 491-495.
Thomas et al. (1991) STP Pharma Sci 1(1): 38-46.
Nugroho, et
Bouwstra Johanna Aaltje
Li Gai Ling
Nugroho Akhmad Karis
Wolff Hans-Michael
Claytor Renee
Harness & Dickey & Pierce P.L.C.
Padmanabhan Sreeni
Schwarz Pharma AG
LandOfFree
Iontophoretic delivery of rotigotine for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iontophoretic delivery of rotigotine for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic delivery of rotigotine for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061382